D. E. Shaw & Co., Inc. Bluebird Bio, Inc. Put Options Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Put Options

19 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	SELL	$4.07 - $10.6 $81,400 - $212,000	-20,000 Reduced 50.0%	20,000 $97,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $244,608 - $445,262	-27,300 Reduced 40.56%	40,000 $400,000
Q3 2021 Nov 15, 2021	BUY	$11.24 - $21.0 $531,652 - $993,300	47,300 Added 236.5%	67,300 $1.29 Million
Q2 2021 Aug 16, 2021	SELL	$18.04 - $22.09 $180,400 - $220,900	-10,000 Reduced 33.33%	20,000 $640,000
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $824,523 - $1.68 Million	-49,700 Reduced 62.36%	30,000 $905,000
Q4 2020 Feb 16, 2021	BUY	$27.5 - $37.92 $266,750 - $367,824	9,700 Added 13.86%	79,700 $3.45 Million
Q3 2020 Nov 16, 2020	SELL	$34.44 - $43.75 $688,800 - $875,000	-20,000 Reduced 22.22%	70,000 $3.78 Million
Q2 2020 Aug 14, 2020	BUY	$27.12 - $45.97 $542,400 - $919,400	20,000 Added 28.57%	90,000 $5.49 Million
Q1 2020 May 15, 2020	SELL	$26.16 - $63.5 $654,000 - $1.59 Million	-25,000 Reduced 26.32%	70,000 $3.22 Million
Q4 2019 Feb 14, 2020	BUY	$46.96 - $61.67 $385,072 - $505,694	8,200 Added 9.45%	95,000 $8.34 Million
Q3 2019 Nov 14, 2019	BUY	$59.47 - $93.1 $850,421 - $1.33 Million	14,300 Added 19.72%	86,800 $7.97 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $1.71 Million - $2.37 Million	22,500 Added 45.0%	72,500 $9.22 Million
Q1 2019 May 15, 2019	BUY	$64.44 - $104.11 $70,884 - $114,521	1,100 Added 2.25%	50,000 $7.87 Million
Q4 2018 Feb 14, 2019	SELL	$59.1 - $93.26 $2.28 Million - $3.59 Million	-38,500 Reduced 44.05%	48,900 $4.85 Million
Q3 2018 Nov 14, 2018	BUY	$88.86 - $117.49 $2.09 Million - $2.76 Million	23,500 Added 36.78%	87,400 $12.8 Million
Q2 2018 Aug 14, 2018	SELL	$99.64 - $127.59 $1.17 Million - $1.49 Million	-11,700 Reduced 15.48%	63,900 $10 Million
Q1 2018 May 15, 2018	BUY	$105.8 - $150.94 $3.7 Million - $5.28 Million	35,000 Added 86.21%	75,600 $12.9 Million
Q4 2017 Feb 14, 2018	BUY	$81.25 - $130.7 $1.39 Million - $2.23 Million	17,100 Added 72.77%	40,600 $7.23 Million
Q3 2017 Nov 14, 2017	BUY	$57.74 - $91.42 $1.36 Million - $2.15 Million	23,500	23,500 $3.23 Million

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$5.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.88 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.73 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.73 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.42 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account